Regulatory Affairs for Biotechnology
BIOENGR X 431.4
This course introduces and reviews the role of Regulatory Affairs (RA) in the biotechnology industry.
Starting at $999.00
As few as 11 weeks
What you can learn.
- Understand the rules and regulations related to getting a medical product approved in the U.S. and Europe
- Learn how to get medical products quickly to market in the US and Europe that are safe and efficacious
- Study an effective strategy to properly approach, deal, plan, and agree with domestic and foreign regulatory bodies
About this course:This course introduces and reviews the role of Regulatory Affairs (RA) in the biotechnology industry. The RA environment embraces the regulations and standards governing product development, from its infancy through post-approval monitoring. In today's regulatory environment, products may be classified as biologics, drugs, medical devices, or a combination of the former products. In most worldwide countries, each type of product is regulated by a different RA authority and often has its own distinct regulations. This course primarily focuses on the U.S. and the European Union (EU) regulatory processes (although other countries such as Canada and Japan are also briefly reviewed). Course topics include: RA history, the various regulatory agencies, accessing RA information, drug submissions, biological submissions, Quality System Regulations (QSR), Good Laboratory Practices (GLP), Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and EU and FDA inspections. Instruction also includes strategies to get products to market quickly and in a safe and efficacious fashion.
Winter 2021 Schedule
These courses are fully online and have no regular meeting times.
Future Offering (Opens November 02, 2020 12:00:00 AM)
This section has no set meeting times.
Instructor: Michael Colvin
Enrollment limited; early enrollment advised.
No refunds after January 18, 2021
Internet access required to access course materials.